| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | YL54 | CTRPv2 | pan-cancer | AAC | -0.012 | 0.8 |
| mRNA | BRD-K45681478 | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | HG-5-113-01 | GDSC1000 | pan-cancer | AAC | 0.013 | 0.8 |
| mRNA | crizotinib:PLX-4032 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.01 | 0.8 |
| mRNA | triptolide | CTRPv2 | pan-cancer | AAC | -0.01 | 0.8 |
| mRNA | MI-2 | CTRPv2 | pan-cancer | AAC | 0.015 | 0.8 |
| mRNA | PI-103 | CTRPv2 | pan-cancer | AAC | -0.01 | 0.8 |
| mRNA | CD-1530 | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | BRD8899 | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | PRL-3 Inhibitor I | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |